XML 23 R12.htm IDEA: XBRL DOCUMENT v3.22.2.2
Common Stock and Earnings Per Share
9 Months Ended
Sep. 30, 2022
Common Stock and Earnings Per Share [Abstract]  
Common Stock and Earnings Per Share

4.  Common Stock and Earnings Per Share

Net income of $5,681 and $4,794 for the three months ended September 30, 2022 and 2021, respectively, and $14,569 and $12,983 for the nine months ended September 30, 2022 and 2021, respectively, is used to calculate both basic and diluted earnings per share.  Basic earnings per share is based on the weighted average number of common shares outstanding.  Diluted earnings per share is based on the weighted average number of common shares outstanding plus potentially dilutive shares.  The dilutive effect of employee stock-based compensation is included in the computation of diluted earnings per share and is calculated using the treasury stock method and expected proceeds upon exercise or issuance of the stock-based compensation.

The following table summarizes the shares used in computing basic and diluted earnings per share:

 
Three Months
Ended September 30
   
Nine Months
Ended September 30
 
   
2022
   
2021
   
2022
   
2021
 
                         
Weighted average common shares, basic
   
14,254,570
     
13,083,762
     
13,853,816
     
13,069,582
 
Effect of dilutive securities:
                               
Employee stock-based compensation
   
703
     
563
     
407
     
347
 
Weighted average common shares, diluted
   
14,255,273
     
13,084,325
     
13,854,223
     
13,069,929
 

On April 5, 2022, the Company closed an underwritten public offering of 975,600 shares of its common stock, with an offering price of $41 per share.  On April 7, 2022, the Company closed on the full exercise of the underwriter’s option to purchase an additional 146,340 shares of its common stock at the same price.  Janney Montgomery Scott LLC was the underwriter in the offering.  The Company received net proceeds in the offering, after deducting offering expenses and underwriters’ discounts and commissions, of $43,970.  The net proceeds were used to repay the Company’s borrowings under its line of credit agreement incurred to fund capital expenditures and acquisitions, and for general corporate purposes.

On March 11, 2013, the Board of Directors, or the Board, authorized a share repurchase program granting the Company authority to repurchase up to 1,200,000 shares of the Company's common stock from time to time.  The stock repurchase program has no specific end date and the Company may repurchase shares in the open market or through privately negotiated transactions.  The Company may suspend or discontinue the repurchase program at any time.  No shares were repurchased during the three or nine months ended September 30, 2022 and 2021.  As of September 30, 2022, 618,004 shares remain authorized for repurchase.